Template:Endocarditis Empiric Antibiotics: Difference between revisions

(Add pediatric empiric dosing section)
 
(5 intermediate revisions by one other user not shown)
Line 14: Line 14:
===[[Dental Procedure Prophylaxis]]===
===[[Dental Procedure Prophylaxis]]===
{{Dental Procedure Endocarditis Prophylaxis Antibiotics}}
{{Dental Procedure Endocarditis Prophylaxis Antibiotics}}
===Pediatric Empiric===
*{{AntibioticDose|disease=Endocarditis|drug=Vancomycin|dose=15mg/kg IV q6hrs (max 2g/dose)|context=Pediatric Empiric|population=Pediatric}} + {{AntibioticDose|disease=Endocarditis|drug=Gentamicin|dose=1mg/kg IV q8hrs|context=Pediatric Empiric|population=Pediatric}}
*{{AntibioticDose|disease=Endocarditis|drug=Nafcillin|dose=50mg/kg IV q6hrs (max 2g/dose)|context=Pediatric MSSA|population=Pediatric}} if MSSA confirmed
*{{AntibioticDose|disease=Endocarditis|drug=Ceftriaxone|dose=100mg/kg/day IV divided q12h (max 4g/day)|context=Pediatric Empiric|population=Pediatric}} as alternative

Latest revision as of 13:03, 20 March 2026

Native Valves

Options:[1]

Suspected MRSA:[1]

Prosthetic Valves (Early)

Early prosthetic valve endocarditis defined as < 12 months post surgery[1]

IV Drug User without Prosthetic Valve

Prosthetic Valve (Late)

Late prosthetic valve endocarditis defined as ≥ 12 months post surgery[1]
  • Same as native valve endocarditis empiric therapy

Dental Procedure Prophylaxis

All antibiotics options are given as a single dose 1 hour prior to the dental procedure

Options:[2]

Pediatric Dosing:

Pediatric Empiric

  1. 1.0 1.1 1.2 1.3 ESC Task Force Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. European Heart Journal (2009) 30, 2369–2413 doi:10.1093/eurheartj/ehp285 PDF
  2. AHA Pocket Card Dental Prophylaxis Endocarditis